The iShares Biotechnology ETF (IBB) saw a significant increase in shares outstanding, with an inflow of approximately $265 million, representing a 2.9% week-over-week rise from 48.7 million to 50.1 million units. This notable demand comes amid a trading session where major components such as Regeneron Pharmaceuticals (REGN) dropped by about 0.6%, argenx SE (ARGX) fell 1.2%, and Alnylam Pharmaceuticals (ALNY) decreased by 1%.
Over the past year, IBB’s share price has fluctuated between a low of $130.25 and a high of $199.05, closing recently at $188.56.
ETFs, like IBB, allow for the buying and selling of units, which are adjusted according to investor demand affecting the underlying holdings.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
